Übersicht über die bisher publizierten gastroenterologischen Empfehlungen der „Klug entscheiden“-Initiative

Pia van Leeuwen

doi:10.1055/a-1133-4566

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2020; 58(07): 645-651
DOI: 10.1055/a-1133-4566

Originalarbeit

Übersicht über die bisher publizierten gastroenterologischen Empfehlungen der „Klug entscheiden“-Initiative

Choosing wisely: Previously published gastroenterological recommendations of the “Klug entscheiden”-initiative

Pia van Leeuwen

DGVS, Berlin, Germany

› Author Affiliations

Abstract

ZusamMenfassung

Dieses Kapitel zeigt eine Übersicht über alle im Rahmen der Initiative „Klug entscheiden“ bisher publizierten gastroenterologischen Klug entscheiden-Empfehlungen.

Abstract

This chapter is a summary of gastroenterological recommendations published as part of the “Klug entscheiden”-initiative.

Schlüsselwörter

Klug entscheiden - Gastroenterologie - Stoffwechselkrankheiten - Verdauungskrankheiten

Key words

Choosing wisely - gastroenterology - metabolic diseases - digestive diseases

Full Text

References

Literatur
1 Preiß JC, Bokemeyer B, Buhr HJ. et al. Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014. Z Gastroenterol 2014; 52: 1431-1484
2 Mahid SS, Minor KS, Soto RE. et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006; 81: 1462-1471
3 Timmer A, Sutherland LR. et al. Oral contraceptive use and smoking are risk factors for relapse in Crohn’s disease. Gastroenterology 1998; 114: 1143-1150
4 Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn’s disease after surgically induced remission. J Clin Gastroenterol 2005; 39: 32-35
5 Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn’s disease. Aliment Pharmacol Ther 2005; 21: 921-931
6 Cosnes J, Carbonnel F, Beaugerie L. et al. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology 1996; 110: 424-431
7 Andreas S, Batra A, Behr J. et al. Tabakentwöhnung bei COPD. Pneumologie 2014; 68: 237-258
8 Dignass A, Preiß JC, Aust DE. et al. Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz. Z Gastroenterol 2011; 49: 1276-1341
9 Steinhart AH, Ewe K, Griffiths AM. et al Corticosteroids for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 2003: Cd000301
10 Lindgren S, Lofberg R, Bergholm L. et al. Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis. Scand J Gastroenterol 2002; 37: 705-710
11 Meyers S, Lerer PK, Feuer EJ. et al. Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, double-blind clinical trial. J Clin Gastroenterol 1987; 9: 50-54
12 Lichtenstein GR, Feagan BG, Cohen RD. et al. Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol 2012; 107: 1409-1422
13 Greten TF, Malek NP, Schmidt S. et al. Diagnostik und Therapie des hepatozellulären Karzinoms. Z Gastroenterol 2013; 51: 1269-1326
14 Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022
15 Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004; 130: 417-422
16 Chen JG, Parkin DM, Chen QG. et al. Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen 2003; 10: 204-209
17 Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014; 11: e1001624
18 (AASLD) AAftSoLD. Five Things Physicians and Patients Should Question. 2015
19 Marrero JA, Ahn J, Rajender Reddy K. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014; 109: 1328-1347 ; quiz 1348
20 Claudon M, Dietrich CF, Choi BI. et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver – update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall in Med 2013; 34: 11-29
21 Shaked O, Siegelman ES, Olthoff K. et al. Biologic and clinical features of benign solid and cystic lesions of the liver. Clin Gastroenterol Hepatol 2011; 9: 547-562.e1–4
22 Ehrl D, Rothaug K, Herzog P. et al. Incidentaloma of the Liver: Management of a Diagnostic and Therapeutic Dilemma. HPB Surgery 2012; 2012: 14
23 Kuo YH, Wang JH, Lu SN. et al. Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound 2009; 37: 132-137
24 Lammert F, Neubrand MW, Bittner R. et al. S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten und der Deutschen Gesellschaft für Viszeralchirurgie zur Diagnostik und Behandlung von Gallensteinen. Z Gastroenterol 2007; 45: 971-1001
25 Friedman GD, Raviola CA, Fireman B. Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization. J Clin Epidemiol 1989; 42: 127-136
26 Attili AF, De Santis A, Capri R. et al. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology 1995; 21: 655-660
27 McSherry CK, Ferstenberg H, Calhoun WF. et al. The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients. Ann Surg 1985; 202: 59-63
28 Gracie WA, Ransohoff DF. The natural history of silent gallstones: the innocent gallstone is not a myth. N Engl J Med 1982; 307: 798-800
29 Sheth S, Bedford A, Chopra S. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy. Am J Gastroenterol 2000; 95: 1402-1410
30 Friedman GD. Natural history of asymptomatic and symptomatic gallstones. Am J Surg 1993; 165: 399-404
31 UK guidelines for the management of acute pancreatitis. Gut 2005; 54 (Suppl. 03) iii1-iii9
32 Tenner S, Baillie J, DeWitt J. et al. American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol 2013; 108: 1400-1415; 1416
33 Working Group IAP/APA Acute Pancreatitis Guidelines: IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13: e1-e15
34 Bollen TL, Singh VK, Maurer R. et al. A comparative evaluation of radiologic and clinical scoring systems in the early prediction of severity in acute pancreatitis. Am J Gastroenterol 2012; 107: 612-619
35 Fleszler F, Friedenberg F, Krevsky B. et al. Abdominal computed tomography prolongs length of stay and is frequently unnecessary in the evaluation of acute pancreatitis. Am J Med Sci 2003; 325: 251-255
36 Spanier BW, Nio Y, van der Hulst RW. et al. Practice and yield of early CT scan in acute pancreatitis: a Dutch Observational Multicenter Study. Pancreatology 2010; 10: 222-228
37 Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet 2015; 386: 85-96
38 London NJ, Leese T, Lavelle JM. et al. Rapid-bolus contrast-enhanced dynamic computed tomography in acute pancreatitis: a prospective study. Br J Surg 1991; 78: 1452-1456
39 Balthazar EJ. Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 2002; 223: 603-613
40 Banks PA, Bollen TL, Dervenis C. et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111
41 Tsuji Y, Yamamoto H, Yazumi S. et al. Perfusion computerized tomography can predict pancreatic necrosis in early stages of severe acute pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1484-1492
42 Seufferlein T, Porzner M, Becker T. et al. S3-Leitlinie zum exokrinen Pankreaskarzinom. Z Gastroenterol 2013; 51: 1395-1440
43 Oettle H, Post S, Neuhaus P. et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Jama 2007; 297: 267-277
44 Ueno H, Kosuge T, Matsuyama Y. et al. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009; 101: 908-915
45 Stocken DD, Buchler MW, Dervenis C. et al. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 2005; 92: 1372-1381
46 Neoptolemos JP, Stocken DD, Bassi C. et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. Jama 2010; 304: 1073-1081
47 Yoshitomi H, Togawa A, Kimura F. et al. A randomized phase II trial of adjuvant chemotherapy with uracil/tegafur and gemcitabine versus gemcitabine alone in patients with resected pancreatic cancer. Cancer 2008; 113: 2448-2456
48 Pox C, Aretz S, Bischoff SC. et al. S3-Leitlinie Kolorektales Karzinom Version 1.0 – Juni 2013 AWMF-Registernummer: 021/007OL. Z Gastroenterol 2013; 51: 753-854
49 Sieg A, Hachmoeller-Eisenbach U, Eisenbach T. Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists. Gastrointest Endosc 2001; 53: 620-627
50 Brenner H, Chang-Claude J, Seiler CM. et al. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 2011; 29: 3761-3767
51 Rex DK, Cummings OW, Helper DJ. et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons [see comment]. Gastroenterology 1996; 111: 1178-1181
52 Singh H, Nugent Z, Mahmud SM. et al Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010; 105: 663-673 ; quiz 674
53 Bertagnolli MM, Eagle CJ, Zauber AG. et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006; 355: 873-884
54 Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2007; 146: 361-364
55 Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-1613
56 Chan AT, Giovannucci EL, Meyerhardt JA. et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. Jama 2005; 294: 914-923
57 Riphaus A, Wehrmann T, Hausmann J. et al. Update S3-Leitlinie „Sedierung in der gastrointestinalen Endoskopie“ 2014 (AWMF-Register-Nr. 021/014). Z Gastroenterol 2015; 53: E1-E1
58 Dumonceau JM, Riphaus A, Aparicio JR. et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anaesthesiologist administration of propofol for GI endoscopy. Eur J Anaesthesiol 2010; 27: 1016-1030
59 Dumonceau JM, Riphaus A, Aparicio JR. et al. European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy. Endoscopy 2010; 42: 960-974
60 Jain R, Ikenberry SO, Anderson MA. et al. Minimum staffing requirements for the performance of GI endoscopy. Gastrointest Endosc 2010; 72: 469-470
61 Vargo JJ, Cohen LB, Rex DK. et al. Position statement: Nonanesthesiologist administration of propofol for GI endoscopy. Gastroenterology 2009; 137: 2161-2167
62 Holster IL, Kuipers EJ. Management of acute nonvariceal upper gastrointestinal bleeding: current policies and future perspectives. World J Gastroenterol 2012; 18: 1202-1207
63 Sbrozzi-Vanni A, Zullo A, Di Giulio E. et al. Low prevalence of idiopathic peptic ulcer disease: an Italian endoscopic survey. Dig Liver Dis 2010; 42: 773-776
64 Gisbert JP, Abraira V. Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 2006; 101: 848-863
65 Sanchez-Delgado J, Gene E, Suarez D. et al. Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 2011; 106: 398-405
66 Götz M. Deutsche Gesellschaft für G, Verdauungs- und S, et al. S2k-Leitlinie Gastrointestinale Blutung. Z Gastroenterol 2017; 55: 883-936
67 Nidegger D, Ragot S, Berthelemy P. et al. Cirrhosis and bleeding: the need for very early management. J Hepatol 2003; 39: 509-514
68 Denzer U, Beilenhoff U, Eickhoff A. et al. S2k-Leitlinie Qualitätsanforderungen in der gastrointestinalen Endoskopie, AWMF Register Nr. 021–022. Z Gastroenterol 2015; 53: E1-E227
69 Tripathi D, Stanley AJ, Hayes PC. et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015; 64: 1680-1704
70 D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354
71 Wells M, Chande N, Adams P. et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther 2012; 35: 1267-1278
72 Banares R, Albillos A, Rincon D. et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609-615
73 Villanueva C, Ortiz J, Sabat M. et al. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: a prospective randomized trial. Hepatology 1999; 30: 384-389
74 Sung JJ, Chung SC, Yung MY. et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346: 1666-1669
75 Besson I, Ingrand P, Person B. et al. Sclerotherapy with or without Octreotide for Acute Variceal Bleeding. New England Journal of Medicine 1995; 333: 555-560
76 de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015; 63: 743-752
77 Augustin S, Gonzalez A, Genesca J. Acute esophageal variceal bleeding: Current strategies and new perspectives. World J Hepatol 2010; 2: 261-274
78 Seo YS, Park SY, Kim MY. et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology 2014; 60: 954-963
79 MacKersie AB, Lane MJ, Gerhardt RT. et al. Nontraumatic acute abdominal pain: unenhanced helical CT compared with three-view acute abdominal series. Radiology 2005; 237: 114-122
80 Stapakis JC, Thickman D. Diagnosis of pneumoperitoneum: abdominal CT vs. upright chest film. J Comput Assist Tomogr 1992; 16: 713-716
81 Haller O, Karlsson L, Nyman R. Can low-dose abdominal CT replace abdominal plain film in evaluation of acute abdominal pain?. Ups J Med Sci 2010; 115: 113-120
82 Hainaux B, Agneessens E, Bertinotti R. et al. Accuracy of MDCT in predicting site of gastrointestinal tract perforation. Am J Roentgenol 2006; 187: 1179-1183
83 Borofsky S, Taffel M, Khati N. et al. The emergency room diagnosis of gastrointestinal tract perforation: the role of CT. Emerg Radiol 2015; 22: 315-327
84 Saturnino PP, Pinto A, Liguori C. et al. Role of Multidetector Computed Tomography in the Diagnosis of Colorectal Perforations. Semin Ultrasound CT MR 2016; 37: 49-53
85 Ng CS, Watson CJ, Palmer CR. et al. Evaluation of early abdominopelvic computed tomography in patients with acute abdominal pain of unknown cause: prospective randomised study. Bmj 2002; 325: 1387
86 Kowalczyk L, Forsmark CE, Ben-David K. et al. Algorithm for the management of endoscopic perforations: a quality improvement project. Am J Gastroenterol 2011; 106: 1022-1027
87 Paspatis GA, Dumonceau JM, Barthet M. et al. Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2014; 46: 693-711
88 Barkun AN, Bardou M, Kuipers EJ. et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2010; 152: 101-113
89 Adler DG, Leighton JA, Davila RE. et al. ASGE guideline: The role of endoscopy in acute non-variceal upper-GI hemorrhage. Gastrointest Endosc 2004; 60: 497-504
90 Gralnek IM, Dumonceau JM, Kuipers EJ. et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: a1-a46
91 Chiu PW, Joeng HK, Choi CL. et al. High-dose omeprazole infusion compared with scheduled second-look endoscopy for prevention of peptic ulcer rebleeding: a randomized controlled trial. Endoscopy 2016; 48: 717-722
92 El Ouali S, Barkun AN, Wyse J. et al. Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc 2012; 76: 283-292
93 Imperiale TF, Kong N. Second-look endoscopy for bleeding peptic ulcer disease: a decision-effectiveness and cost-effectiveness analysis. J Clin Gastroenterol 2012; 46: e71-e75
94 Qureshi W, Adler DG, Davila R. et al. ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005. Gastrointest Endosc 2005; 62: 651-655
95 Theilacker C, Ludewig K, Serr A. et al. Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study. Clin Infect Dis 2016; 62: 871-878
96 RKI. Wissenschaftliche Begründung für die Aktualisierung der Empfehlungen zur Indikationsimpfung gegen Pneumokokken für Risikogruppen. EpiBull 2016; 37: 385-406
97 Ljungman P, Cordonnier C, Einsele H. et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009; 44: 521-526
98 Onkologie AIidHu. Empfehlung der AGIHO zur Pneumokokkenimpfung bei hämatologischen und onkologischen Patienten im Erwachsenenalter. 2019
99 French N, Gordon SB, Mwalukomo T. et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010; 362: 812-822
100 French N, Nakiyingi J, Carpenter LM. et al. 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355: 2106-2111